WILL YOU BE UNDERGOING A SPINAL FUSION SURGICAL PROCEDURE IN THE FUTURE?

If so, you may be able to participate in a medical research study to evaluate an investigational vaccine against Staphylococcus aureus (staph) infections.

 
WELCOME

Welcome to the STRIVE (STaphylococcus aureus suRgical Inpatient Vaccine Efficacy) study website. This site provides information on a medical research study to evaluate an investigational vaccine against Staphylococcus aureus infections in adults planning to undergo spinal fusion surgery.

STAPHYLOCOCCUS AUREUS

Staphylococcus aureus (also known as staph) is a germ frequently found in the skin and is one of the most common germs found in surgical infections. About 1 to 3 people in every 100 develop a surgical site infection after spinal surgery.

THE PURPOSE

The purpose of the STRIVE study is to evaluate the safety and efficacy of an investigational vaccine against Staphylococcus aureus and examine whether a single vaccination given 10 – 60 days before surgery can prevent staph infections after spinal fusion surgery.

PARTICIPATION

If you are planning to undergo spinal fusion surgery and would be interested in participating in this study or would like more information, please see the About the STRIVE Study page for additional information or contact one of our study sites listed on the Site Locations page.

FIND A PARTICIPATING LOCATION

Ready to speak with a Study Coordinator? Click the button below to view the current sites participating in the study.

Find Locations

ABOUT STRIVE STUDY

Doctor with female patient

The STRIVE research study will evaluate the safety and efficacy of an investigational vaccine against Staphylococcus aureus (staph) infections after spinal surgery.

To learn more about the study and eligibility to participate, please visit our About section.

Learn more about the STRIVE study